Colony Group LLC Reviva Pharmaceuticals Holdings, Inc. Transaction History
Colony Group LLC
- $6.66 Billion
- Q3 2023
A detailed history of Colony Group LLC transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Colony Group LLC holds 171,000 shares of RVPH stock, worth $218,880. This represents 0.01% of its overall portfolio holdings.
Number of Shares
171,000
Previous 155,000
10.32%
Holding current value
$218,880
Previous $908,000
8.15%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding RVPH
# of Institutions
32Shares Held
5.55MCall Options Held
350KPut Options Held
97.8K-
Woodline Partners LP San Francisco, CA1.06MShares$1.35 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA1MShares$1.28 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny855KShares$1.09 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY827KShares$1.06 Million0.02% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT504KShares$644,9330.26% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $26.2M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...